Organon & Co

Financials

Visão geral Relatórios Estatísticas Dividendos

Cash from operating activities 2.46 B858 M799 M939 M700 M 700 M Cash from investing activities -481 M-420 M-260 M-513 M-390 M -390 M Cash from financing activities -1.33 B-433 M-569 M-368 M-561 M -561 M Free cash flow 2.07 B538 M546 M659 M414 M 414 M

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co

Notícias

Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note

Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN)

Dow Dips Over 250 Points: Investor Sentiment Declines, Greed Index Remains In 'Fear' Zone - Goldman Sachs

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon Jumps 25% As Report Cites $12 Billion Sun Pharma Offer

S&P Futures Waver With All Eyes on Key U.S. Inflation Data, U.S.-Iran Talks Awaited

Ações da Organon sobem 8,4% após relato de oferta de US$ 12 bilhões da Sun Pharma

Ações da Organon & Co atingem mínima de 52 semanas a US$ 5,76

Organon apresenta dados do creme VTAMA para dermatite atópica na AAD

Ações da Organon & Co atingem mínima de 52 semanas a US$ 6,17

Altius aposta no lítio para triplicar receita até 2030